Torrent Pharmaceuticals Limited Discontinued
FDA Approved Drugs

Torrent Pharmaceuticals Limited Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 148
  • Latest Approval Date Feb 10, 2026
  • Data Source FDA
  • First Approval Date Dec 07, 2005
All
326
View
Unclassified
13
View
Discontinued
148
View
RX
165
View
Company Overview

Company

Torrent Pharmaceuticals Limited Discontinued

Country

India

Website

Visit Website

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Torrent Pharmaceuticals Limited Discontinued

Off. Ashram Road, Ahmedabad - 380 009, Gujarat

India

www.torrentpharma.com/ View on Map
FDA Approved Drug Records ( 148 records )
2024
26 Jan
Discontinued Application: 213706

Drug Name

ACETAZOLAMIDE

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2024-01-26

213706 / 1

Active Ingredient

ACETAZOLAMIDE

Application Number

213706

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2024-01-26

Regulatory Status

Discontinued

2024
26 Jan
Discontinued Application: 213706

Drug Name

ACETAZOLAMIDE

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2024-01-26

213706 / 2

Active Ingredient

ACETAZOLAMIDE

Application Number

213706

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2024-01-26

Regulatory Status

Discontinued

2011
18 Jul
Discontinued Application: 79054

Drug Name

ALFUZOSIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2011-07-18

79054 / 1

Active Ingredient

ALFUZOSIN HYDROCHLORIDE

Application Number

79054

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2011-07-18

Regulatory Status

Discontinued

2016
25 Nov
Discontinued Application: 202933

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;20MG

Approval Date

2016-11-25

202933 / 1

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

202933

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;20MG

Approval Date

2016-11-25

Regulatory Status

Discontinued

2016
25 Nov
Discontinued Application: 202933

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2016-11-25

202933 / 2

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

202933

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2016-11-25

Regulatory Status

Discontinued

2016
25 Nov
Discontinued Application: 202933

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;20MG

Approval Date

2016-11-25

202933 / 3

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

202933

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;20MG

Approval Date

2016-11-25

Regulatory Status

Discontinued

2016
25 Nov
Discontinued Application: 202933

Drug Name

AMLODIPINE AND OLMESARTAN MEDOXOMIL

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2016-11-25

202933 / 4

Active Ingredient

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Application Number

202933

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2016-11-25

Regulatory Status

Discontinued

2008
22 Sep
Discontinued Application: 78573

Drug Name

AMLODIPINE BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2008-09-22

78573 / 1

Active Ingredient

AMLODIPINE BESYLATE

Application Number

78573

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2008-09-22

Regulatory Status

Discontinued

2008
22 Sep
Discontinued Application: 78573

Drug Name

AMLODIPINE BESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2008-09-22

78573 / 2

Active Ingredient

AMLODIPINE BESYLATE

Application Number

78573

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2008-09-22

Regulatory Status

Discontinued

2008
22 Sep
Discontinued Application: 78573

Drug Name

AMLODIPINE BESYLATE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2008-09-22

78573 / 3

Active Ingredient

AMLODIPINE BESYLATE

Application Number

78573

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2008-09-22

Regulatory Status

Discontinued

2015
30 Mar
Discontinued Application: 202377

Drug Name

AMLODIPINE BESYLATE AND VALSARTAN

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;160MG

Approval Date

2015-03-30

202377 / 1

Active Ingredient

AMLODIPINE BESYLATE; VALSARTAN

Application Number

202377

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;160MG

Approval Date

2015-03-30

Regulatory Status

Discontinued

2015
30 Mar
Discontinued Application: 202377

Drug Name

AMLODIPINE BESYLATE AND VALSARTAN

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;320MG

Approval Date

2015-03-30

202377 / 2

Active Ingredient

AMLODIPINE BESYLATE; VALSARTAN

Application Number

202377

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;320MG

Approval Date

2015-03-30

Regulatory Status

Discontinued

2015
30 Mar
Discontinued Application: 202377

Drug Name

AMLODIPINE BESYLATE AND VALSARTAN

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;160MG

Approval Date

2015-03-30

202377 / 3

Active Ingredient

AMLODIPINE BESYLATE; VALSARTAN

Application Number

202377

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;160MG

Approval Date

2015-03-30

Regulatory Status

Discontinued

2015
30 Mar
Discontinued Application: 202377

Drug Name

AMLODIPINE BESYLATE AND VALSARTAN

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;320MG

Approval Date

2015-03-30

202377 / 4

Active Ingredient

AMLODIPINE BESYLATE; VALSARTAN

Application Number

202377

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;320MG

Approval Date

2015-03-30

Regulatory Status

Discontinued

2015
03 Jun
Discontinued Application: 201593

Drug Name

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;160MG

Approval Date

2015-06-03

201593 / 1

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Application Number

201593

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;160MG

Approval Date

2015-06-03

Regulatory Status

Discontinued

2015
03 Jun
Discontinued Application: 201593

Drug Name

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;25MG;160MG

Approval Date

2015-06-03

201593 / 2

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Application Number

201593

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;25MG;160MG

Approval Date

2015-06-03

Regulatory Status

Discontinued

2015
03 Jun
Discontinued Application: 201593

Drug Name

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;160MG

Approval Date

2015-06-03

201593 / 3

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Application Number

201593

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;160MG

Approval Date

2015-06-03

Regulatory Status

Discontinued

2015
03 Jun
Discontinued Application: 201593

Drug Name

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;25MG;160MG

Approval Date

2015-06-03

201593 / 4

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Application Number

201593

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;25MG;160MG

Approval Date

2015-06-03

Regulatory Status

Discontinued

2015
03 Jun
Discontinued Application: 201593

Drug Name

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;320MG

Approval Date

2015-06-03

201593 / 5

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Application Number

201593

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;320MG

Approval Date

2015-06-03

Regulatory Status

Discontinued

2024
17 Dec
Discontinued Application: 210156

Drug Name

APIXABAN

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2024-12-17

210156 / 1

Active Ingredient

APIXABAN

Application Number

210156

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2024-12-17

Regulatory Status

Discontinued

2024
17 Dec
Discontinued Application: 210156

Drug Name

APIXABAN

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2024-12-17

210156 / 2

Active Ingredient

APIXABAN

Application Number

210156

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2024-12-17

Regulatory Status

Discontinued

2025
20 Jun
Discontinued Application: 211834

Drug Name

APREMILAST

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-06-20

211834 / 1

Active Ingredient

APREMILAST

Application Number

211834

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-06-20

Regulatory Status

Discontinued

2025
20 Jun
Discontinued Application: 211834

Drug Name

APREMILAST

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2025-06-20

211834 / 2

Active Ingredient

APREMILAST

Application Number

211834

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2025-06-20

Regulatory Status

Discontinued

2025
20 Jun
Discontinued Application: 211834

Drug Name

APREMILAST

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2025-06-20

211834 / 3

Active Ingredient

APREMILAST

Application Number

211834

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2025-06-20

Regulatory Status

Discontinued

2014
31 Oct
Discontinued Application: 203969

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-10-31

203969 / 1

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

203969

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-10-31

Regulatory Status

Discontinued

2014
31 Oct
Discontinued Application: 203969

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-10-31

203969 / 2

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

203969

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-10-31

Regulatory Status

Discontinued

2014
31 Oct
Discontinued Application: 203969

Drug Name

BUPROPION HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2014-10-31

203969 / 3

Active Ingredient

BUPROPION HYDROCHLORIDE

Application Number

203969

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2014-10-31

Regulatory Status

Discontinued

2005
07 Dec
Discontinued Application: 77272

Drug Name

CARBAMAZEPINE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2005-12-07

77272 / 1

Active Ingredient

CARBAMAZEPINE

Application Number

77272

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2005-12-07

Regulatory Status

Discontinued

2005
07 Dec
Discontinued Application: 77272

Drug Name

CARBAMAZEPINE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2005-12-07

77272 / 3

Active Ingredient

CARBAMAZEPINE

Application Number

77272

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2005-12-07

Regulatory Status

Discontinued

2005
07 Dec
Discontinued Application: 77272

Drug Name

CARBAMAZEPINE

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2005-12-07

77272 / 4

Active Ingredient

CARBAMAZEPINE

Application Number

77272

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2005-12-07

Regulatory Status

Discontinued

2010
15 Apr
Discontinued Application: 79191

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-04-15

79191 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

79191

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-04-15

Regulatory Status

Discontinued

2010
15 Apr
Discontinued Application: 79191

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2010-04-15

79191 / 4

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

79191

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2010-04-15

Regulatory Status

Discontinued

2010
15 Apr
Discontinued Application: 79191

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2010-04-15

79191 / 2

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

79191

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2010-04-15

Regulatory Status

Discontinued

2010
15 Apr
Discontinued Application: 79191

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2010-04-15

79191 / 3

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

79191

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2010-04-15

Regulatory Status

Discontinued

2023
14 Dec
Discontinued Application: 217385

Drug Name

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

Product Number

1

Dosage Form

-

Strength

5MG;2.5MG

Approval Date

2023-12-14

217385 / 1

Active Ingredient

CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE

Application Number

217385

Product Number

1

Dosage Form

-

Strength

5MG;2.5MG

Approval Date

2023-12-14

Regulatory Status

Discontinued

2019
25 Oct
Discontinued Application: 212926

Drug Name

CLOBETASOL PROPIONATE

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2019-10-25

212926 / 1

Active Ingredient

CLOBETASOL PROPIONATE

Application Number

212926

Product Number

1

Dosage Form

-

Strength

0.05%

Approval Date

2019-10-25

Regulatory Status

Discontinued

2024
05 Nov
Discontinued Application: 209426

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2024-11-05

209426 / 1

Active Ingredient

DEFERASIROX

Application Number

209426

Product Number

1

Dosage Form

-

Strength

125MG

Approval Date

2024-11-05

Regulatory Status

Discontinued

2024
05 Nov
Discontinued Application: 209426

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2024-11-05

209426 / 2

Active Ingredient

DEFERASIROX

Application Number

209426

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2024-11-05

Regulatory Status

Discontinued

2024
05 Nov
Discontinued Application: 209426

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2024-11-05

209426 / 3

Active Ingredient

DEFERASIROX

Application Number

209426

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

2024-11-05

Regulatory Status

Discontinued

2025
06 Jan
Discontinued Application: 210390

Drug Name

DIMETHYL FUMARATE

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2025-01-06

210390 / 1

Active Ingredient

DIMETHYL FUMARATE

Application Number

210390

Product Number

1

Dosage Form

-

Strength

120MG

Approval Date

2025-01-06

Regulatory Status

Discontinued

2025
06 Jan
Discontinued Application: 210390

Drug Name

DIMETHYL FUMARATE

Product Number

2

Dosage Form

-

Strength

240MG

Approval Date

2025-01-06

210390 / 2

Active Ingredient

DIMETHYL FUMARATE

Application Number

210390

Product Number

2

Dosage Form

-

Strength

240MG

Approval Date

2025-01-06

Regulatory Status

Discontinued

2024
15 Apr
Discontinued Application: 214356

Drug Name

DOXYCYCLINE HYCLATE

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2024-04-15

214356 / 1

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

214356

Product Number

1

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2024-04-15

Regulatory Status

Discontinued

2024
15 Apr
Discontinued Application: 214356

Drug Name

DOXYCYCLINE HYCLATE

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2024-04-15

214356 / 2

Active Ingredient

DOXYCYCLINE HYCLATE

Application Number

214356

Product Number

2

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2024-04-15

Regulatory Status

Discontinued

2013
11 Dec
Discontinued Application: 90774

Drug Name

DULOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2013-12-11

90774 / 1

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

90774

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2013-12-11

Regulatory Status

Discontinued

2013
11 Dec
Discontinued Application: 90774

Drug Name

DULOXETINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-12-11

90774 / 2

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

90774

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-12-11

Regulatory Status

Discontinued

2013
11 Dec
Discontinued Application: 90774

Drug Name

DULOXETINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2013-12-11

90774 / 3

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

90774

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2013-12-11

Regulatory Status

Discontinued

2015
19 Oct
Discontinued Application: 203636

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-10-19

203636 / 1

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

203636

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-10-19

Regulatory Status

Discontinued

2015
19 Oct
Discontinued Application: 203636

Drug Name

ESOMEPRAZOLE MAGNESIUM

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2015-10-19

203636 / 2

Active Ingredient

ESOMEPRAZOLE MAGNESIUM

Application Number

203636

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2015-10-19

Regulatory Status

Discontinued

2025
27 Jan
Discontinued Application: 209461

Drug Name

EZETIMIBE AND SIMVASTATIN

Product Number

1

Dosage Form

-

Strength

10MG;10MG

Approval Date

2025-01-27

209461 / 1

Active Ingredient

EZETIMIBE; SIMVASTATIN

Application Number

209461

Product Number

1

Dosage Form

-

Strength

10MG;10MG

Approval Date

2025-01-27

Regulatory Status

Discontinued

2025
27 Jan
Discontinued Application: 209461

Drug Name

EZETIMIBE AND SIMVASTATIN

Product Number

2

Dosage Form

-

Strength

10MG;20MG

Approval Date

2025-01-27

209461 / 2

Active Ingredient

EZETIMIBE; SIMVASTATIN

Application Number

209461

Product Number

2

Dosage Form

-

Strength

10MG;20MG

Approval Date

2025-01-27

Regulatory Status

Discontinued

2025
27 Jan
Discontinued Application: 209461

Drug Name

EZETIMIBE AND SIMVASTATIN

Product Number

3

Dosage Form

-

Strength

10MG;40MG

Approval Date

2025-01-27

209461 / 3

Active Ingredient

EZETIMIBE; SIMVASTATIN

Application Number

209461

Product Number

3

Dosage Form

-

Strength

10MG;40MG

Approval Date

2025-01-27

Regulatory Status

Discontinued

2025
27 Jan
Discontinued Application: 209461

Drug Name

EZETIMIBE AND SIMVASTATIN

Product Number

4

Dosage Form

-

Strength

10MG;80MG

Approval Date

2025-01-27

209461 / 4

Active Ingredient

EZETIMIBE; SIMVASTATIN

Application Number

209461

Product Number

4

Dosage Form

-

Strength

10MG;80MG

Approval Date

2025-01-27

Regulatory Status

Discontinued

2023
19 Dec
Discontinued Application: 211837

Drug Name

FEBUXOSTAT

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2023-12-19

211837 / 1

Active Ingredient

FEBUXOSTAT

Application Number

211837

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2023-12-19

Regulatory Status

Discontinued

2023
19 Dec
Discontinued Application: 211837

Drug Name

FEBUXOSTAT

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2023-12-19

211837 / 2

Active Ingredient

FEBUXOSTAT

Application Number

211837

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2023-12-19

Regulatory Status

Discontinued

2024
22 Jan
Discontinued Application: 217094

Drug Name

FLUPHENAZINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-01-22

217094 / 1

Active Ingredient

FLUPHENAZINE HYDROCHLORIDE

Application Number

217094

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2024-01-22

Regulatory Status

Discontinued

2024
22 Jan
Discontinued Application: 217094

Drug Name

FLUPHENAZINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2024-01-22

217094 / 2

Active Ingredient

FLUPHENAZINE HYDROCHLORIDE

Application Number

217094

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2024-01-22

Regulatory Status

Discontinued

2024
22 Jan
Discontinued Application: 217094

Drug Name

FLUPHENAZINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2024-01-22

217094 / 3

Active Ingredient

FLUPHENAZINE HYDROCHLORIDE

Application Number

217094

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2024-01-22

Regulatory Status

Discontinued

2024
22 Jan
Discontinued Application: 217094

Drug Name

FLUPHENAZINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2024-01-22

217094 / 4

Active Ingredient

FLUPHENAZINE HYDROCHLORIDE

Application Number

217094

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2024-01-22

Regulatory Status

Discontinued

2014
31 Oct
Discontinued Application: 203240

Drug Name

FLUVOXAMINE MALEATE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-10-31

203240 / 1

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

203240

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2014-10-31

Regulatory Status

Discontinued

2014
31 Oct
Discontinued Application: 203240

Drug Name

FLUVOXAMINE MALEATE

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-10-31

203240 / 2

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

203240

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2014-10-31

Regulatory Status

Discontinued

2024
18 Mar
Discontinued Application: 215925

Drug Name

IBUPROFEN AND FAMOTIDINE

Product Number

1

Dosage Form

-

Strength

26.6MG;800MG

Approval Date

2024-03-18

215925 / 1

Active Ingredient

FAMOTIDINE; IBUPROFEN

Application Number

215925

Product Number

1

Dosage Form

-

Strength

26.6MG;800MG

Approval Date

2024-03-18

Regulatory Status

Discontinued

2013
23 Dec
Discontinued Application: 203370

Drug Name

LAMOTRIGINE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2013-12-23

203370 / 4

Active Ingredient

LAMOTRIGINE

Application Number

203370

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2013-12-23

Regulatory Status

Discontinued

2023
17 Feb
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-02-17

213405 / 1

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2023-02-17

Regulatory Status

Discontinued

2023
17 Feb
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-02-17

213405 / 2

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-02-17

Regulatory Status

Discontinued

2023
03 Aug
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2023-08-03

213405 / 3

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2023-08-03

Regulatory Status

Discontinued

2025
04 Nov
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2025-11-04

213405 / 4

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2025-11-04

Regulatory Status

Discontinued

2026
10 Feb
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2026-02-10

213405 / 5

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

2026-02-10

Regulatory Status

Discontinued

2026
10 Feb
Discontinued Application: 213405

Drug Name

LENALIDOMIDE

Product Number

6

Dosage Form

-

Strength

5MG

Approval Date

2026-02-10

213405 / 6

Active Ingredient

LENALIDOMIDE

Application Number

213405

Product Number

6

Dosage Form

-

Strength

5MG

Approval Date

2026-02-10

Regulatory Status

Discontinued

2011
20 Jun
Discontinued Application: 90722

Drug Name

LEVOFLOXACIN

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-06-20

90722 / 1

Active Ingredient

LEVOFLOXACIN

Application Number

90722

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-06-20

Regulatory Status

Discontinued

2011
20 Jun
Discontinued Application: 90722

Drug Name

LEVOFLOXACIN

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2011-06-20

90722 / 2

Active Ingredient

LEVOFLOXACIN

Application Number

90722

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2011-06-20

Regulatory Status

Discontinued

2011
20 Jun
Discontinued Application: 90722

Drug Name

LEVOFLOXACIN

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2011-06-20

90722 / 3

Active Ingredient

LEVOFLOXACIN

Application Number

90722

Product Number

3

Dosage Form

-

Strength

750MG

Approval Date

2011-06-20

Regulatory Status

Discontinued

2010
06 Oct
Discontinued Application: 90467

Drug Name

LOSARTAN POTASSIUM

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

90467 / 1

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90467

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

Regulatory Status

Discontinued

2010
06 Oct
Discontinued Application: 90467

Drug Name

LOSARTAN POTASSIUM

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

90467 / 2

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90467

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

Regulatory Status

Discontinued

2010
06 Oct
Discontinued Application: 90467

Drug Name

LOSARTAN POTASSIUM

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

90467 / 3

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90467

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

Regulatory Status

Discontinued

2010
06 Oct
Discontinued Application: 90528

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;50MG

Approval Date

2010-10-06

90528 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

90528

Product Number

1

Dosage Form

-

Strength

12.5MG;50MG

Approval Date

2010-10-06

Regulatory Status

Discontinued

2010
06 Oct
Discontinued Application: 90528

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

25MG;100MG

Approval Date

2010-10-06

90528 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

90528

Product Number

2

Dosage Form

-

Strength

25MG;100MG

Approval Date

2010-10-06

Regulatory Status

Discontinued

2010
06 Apr
Discontinued Application: 90528

Drug Name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

12.5MG;100MG

Approval Date

2010-04-06

90528 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Application Number

90528

Product Number

3

Dosage Form

-

Strength

12.5MG;100MG

Approval Date

2010-04-06

Regulatory Status

Discontinued

2015
13 Oct
Discontinued Application: 200155

Drug Name

MEMANTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-10-13

200155 / 1

Active Ingredient

MEMANTINE HYDROCHLORIDE

Application Number

200155

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-10-13

Regulatory Status

Discontinued

2015
13 Oct
Discontinued Application: 200155

Drug Name

MEMANTINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-10-13

200155 / 2

Active Ingredient

MEMANTINE HYDROCHLORIDE

Application Number

200155

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-10-13

Regulatory Status

Discontinued

2007
24 Jan
Discontinued Application: 77711

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2007-01-24

77711 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

77711

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2007-01-24

Regulatory Status

Discontinued

2007
24 Jan
Discontinued Application: 77711

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2007-01-24

77711 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

77711

Product Number

2

Dosage Form

-

Strength

850MG

Approval Date

2007-01-24

Regulatory Status

Discontinued

2007
24 Jan
Discontinued Application: 77711

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2007-01-24

77711 / 3

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

77711

Product Number

3

Dosage Form

-

Strength

1GM

Approval Date

2007-01-24

Regulatory Status

Discontinued

2010
18 Feb
Discontinued Application: 79226

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2010-02-18

79226 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

79226

Product Number

1

Dosage Form

-

Strength

750MG

Approval Date

2010-02-18

Regulatory Status

Discontinued

2009
30 Dec
Discontinued Application: 90014

Drug Name

METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2009-12-30

90014 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE

Application Number

90014

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2009-12-30

Regulatory Status

Discontinued

2014
03 Apr
Discontinued Application: 200160

Drug Name

MOXIFLOXACIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2014-04-03

200160 / 1

Active Ingredient

MOXIFLOXACIN HYDROCHLORIDE

Application Number

200160

Product Number

1

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2014-04-03

Regulatory Status

Discontinued

2018
02 Mar
Discontinued Application: 203966

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2018-03-02

203966 / 1

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203966

Product Number

1

Dosage Form

-

Strength

EQ 2.5MG BASE

Approval Date

2018-03-02

Regulatory Status

Discontinued

2018
02 Mar
Discontinued Application: 203966

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-03-02

203966 / 2

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203966

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2018-03-02

Regulatory Status

Discontinued

2018
02 Mar
Discontinued Application: 203966

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-03-02

203966 / 3

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203966

Product Number

3

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2018-03-02

Regulatory Status

Discontinued

2018
02 Mar
Discontinued Application: 203966

Drug Name

NEBIVOLOL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-03-02

203966 / 4

Active Ingredient

NEBIVOLOL HYDROCHLORIDE

Application Number

203966

Product Number

4

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2018-03-02

Regulatory Status

Discontinued

2020
14 Jul
Discontinued Application: 213142

Drug Name

NYSTATIN AND TRIAMCINOLONE ACETONIDE

Product Number

1

Dosage Form

-

Strength

100,000 UNITS/GM;0.1%

Approval Date

2020-07-14

213142 / 1

Active Ingredient

NYSTATIN; TRIAMCINOLONE ACETONIDE

Application Number

213142

Product Number

1

Dosage Form

-

Strength

100,000 UNITS/GM;0.1%

Approval Date

2020-07-14

Regulatory Status

Discontinued

2017
24 Apr
Discontinued Application: 202375

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-04-24

202375 / 1

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

202375

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2017-04-24

Regulatory Status

Discontinued

2017
24 Apr
Discontinued Application: 202375

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-24

202375 / 2

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

202375

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-24

Regulatory Status

Discontinued

2017
24 Apr
Discontinued Application: 202375

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2017-04-24

202375 / 3

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

202375

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2017-04-24

Regulatory Status

Discontinued

2017
03 May
Discontinued Application: 206515

Drug Name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2017-05-03

206515 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

206515

Product Number

1

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2017-05-03

Regulatory Status

Discontinued

2017
03 May
Discontinued Application: 206515

Drug Name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;40MG

Approval Date

2017-05-03

206515 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

206515

Product Number

2

Dosage Form

-

Strength

12.5MG;40MG

Approval Date

2017-05-03

Regulatory Status

Discontinued

2017
03 May
Discontinued Application: 206515

Drug Name

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;40MG

Approval Date

2017-05-03

206515 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

206515

Product Number

3

Dosage Form

-

Strength

25MG;40MG

Approval Date

2017-05-03

Regulatory Status

Discontinued

2016
26 Oct
Discontinued Application: 203580

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;20MG

Approval Date

2016-10-26

203580 / 1

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

203580

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;20MG

Approval Date

2016-10-26

Regulatory Status

Discontinued

2016
26 Oct
Discontinued Application: 203580

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;40MG

Approval Date

2016-10-26

203580 / 4

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

203580

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;40MG

Approval Date

2016-10-26

Regulatory Status

Discontinued

2016
26 Oct
Discontinued Application: 203580

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;40MG

Approval Date

2016-10-26

203580 / 5

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

203580

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;40MG

Approval Date

2016-10-26

Regulatory Status

Discontinued

2013
13 Feb
Discontinued Application: 91298

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

91298 / 1

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

91298

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

Regulatory Status

Discontinued

2013
13 Feb
Discontinued Application: 91298

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

91298 / 2

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

91298

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

Regulatory Status

Discontinued

2013
13 Feb
Discontinued Application: 91298

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

91298 / 3

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

91298

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

Regulatory Status

Discontinued

2024
06 Feb
Discontinued Application: 213986

Drug Name

POTASSIUM CITRATE

Product Number

1

Dosage Form

-

Strength

5MEQ

Approval Date

2024-02-06

213986 / 1

Active Ingredient

POTASSIUM CITRATE

Application Number

213986

Product Number

1

Dosage Form

-

Strength

5MEQ

Approval Date

2024-02-06

Regulatory Status

Discontinued

2024
06 Feb
Discontinued Application: 213986

Drug Name

POTASSIUM CITRATE

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2024-02-06

213986 / 2

Active Ingredient

POTASSIUM CITRATE

Application Number

213986

Product Number

2

Dosage Form

-

Strength

10MEQ

Approval Date

2024-02-06

Regulatory Status

Discontinued

2024
06 Feb
Discontinued Application: 213986

Drug Name

POTASSIUM CITRATE

Product Number

3

Dosage Form

-

Strength

15MEQ

Approval Date

2024-02-06

213986 / 3

Active Ingredient

POTASSIUM CITRATE

Application Number

213986

Product Number

3

Dosage Form

-

Strength

15MEQ

Approval Date

2024-02-06

Regulatory Status

Discontinued

2025
24 Jun
Discontinued Application: 218778

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

218778 / 1

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

218778

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-06-24

Regulatory Status

Discontinued

2025
24 Jun
Discontinued Application: 218778

Drug Name

PRUCALOPRIDE SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

218778 / 2

Active Ingredient

PRUCALOPRIDE SUCCINATE

Application Number

218778

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2025-06-24

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2012-03-27

200363 / 1

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2012-03-27

200363 / 2

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2012-03-27

200363 / 3

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

4

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2012-03-27

200363 / 4

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

4

Dosage Form

-

Strength

EQ 200MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

5

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2012-03-27

200363 / 5

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

5

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 200363

Drug Name

QUETIAPINE FUMARATE

Product Number

6

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2012-03-27

200363 / 6

Active Ingredient

QUETIAPINE FUMARATE

Application Number

200363

Product Number

6

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2012-03-27

Regulatory Status

Discontinued

2025
04 Feb
Discontinued Application: 210407

Drug Name

RANOLAZINE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2025-02-04

210407 / 1

Active Ingredient

RANOLAZINE

Application Number

210407

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2025-02-04

Regulatory Status

Discontinued

2025
04 Feb
Discontinued Application: 210407

Drug Name

RANOLAZINE

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2025-02-04

210407 / 2

Active Ingredient

RANOLAZINE

Application Number

210407

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2025-02-04

Regulatory Status

Discontinued

2018
06 Aug
Discontinued Application: 208272

Drug Name

ROFLUMILAST

Product Number

1

Dosage Form

-

Strength

500MCG

Approval Date

2018-08-06

208272 / 1

Active Ingredient

ROFLUMILAST

Application Number

208272

Product Number

1

Dosage Form

-

Strength

500MCG

Approval Date

2018-08-06

Regulatory Status

Discontinued

2024
18 Oct
Discontinued Application: 208272

Drug Name

ROFLUMILAST

Product Number

2

Dosage Form

-

Strength

250MCG

Approval Date

2024-10-18

208272 / 2

Active Ingredient

ROFLUMILAST

Application Number

208272

Product Number

2

Dosage Form

-

Strength

250MCG

Approval Date

2024-10-18

Regulatory Status

Discontinued

2007
06 Feb
Discontinued Application: 77765

Drug Name

SERTRALINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2007-02-06

77765 / 1

Active Ingredient

SERTRALINE HYDROCHLORIDE

Application Number

77765

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2007-02-06

Regulatory Status

Discontinued

2007
06 Feb
Discontinued Application: 77765

Drug Name

SERTRALINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2007-02-06

77765 / 2

Active Ingredient

SERTRALINE HYDROCHLORIDE

Application Number

77765

Product Number

2

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2007-02-06

Regulatory Status

Discontinued

2007
06 Feb
Discontinued Application: 77765

Drug Name

SERTRALINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2007-02-06

77765 / 3

Active Ingredient

SERTRALINE HYDROCHLORIDE

Application Number

77765

Product Number

3

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2007-02-06

Regulatory Status

Discontinued

2025
27 Feb
Discontinued Application: 215909

Drug Name

SEVELAMER CARBONATE

Product Number

1

Dosage Form

-

Strength

800MG/PACKET

Approval Date

2025-02-27

215909 / 1

Active Ingredient

SEVELAMER CARBONATE

Application Number

215909

Product Number

1

Dosage Form

-

Strength

800MG/PACKET

Approval Date

2025-02-27

Regulatory Status

Discontinued

2025
27 Feb
Discontinued Application: 215909

Drug Name

SEVELAMER CARBONATE

Product Number

2

Dosage Form

-

Strength

2.4GM/PACKET

Approval Date

2025-02-27

215909 / 2

Active Ingredient

SEVELAMER CARBONATE

Application Number

215909

Product Number

2

Dosage Form

-

Strength

2.4GM/PACKET

Approval Date

2025-02-27

Regulatory Status

Discontinued

2025
10 Feb
Discontinued Application: 210396

Drug Name

SILODOSIN

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2025-02-10

210396 / 1

Active Ingredient

SILODOSIN

Application Number

210396

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

2025-02-10

Regulatory Status

Discontinued

2025
10 Feb
Discontinued Application: 210396

Drug Name

SILODOSIN

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2025-02-10

210396 / 2

Active Ingredient

SILODOSIN

Application Number

210396

Product Number

2

Dosage Form

-

Strength

8MG

Approval Date

2025-02-10

Regulatory Status

Discontinued

2025
04 Mar
Discontinued Application: 209424

Drug Name

SOLIFENACIN SUCCINATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2025-03-04

209424 / 1

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209424

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2025-03-04

Regulatory Status

Discontinued

2025
04 Mar
Discontinued Application: 209424

Drug Name

SOLIFENACIN SUCCINATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2025-03-04

209424 / 2

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209424

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2025-03-04

Regulatory Status

Discontinued

2014
08 Jan
Discontinued Application: 202517

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2014-01-08

202517 / 1

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

202517

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;40MG

Approval Date

2014-01-08

Regulatory Status

Discontinued

2014
08 Jan
Discontinued Application: 202517

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2014-01-08

202517 / 2

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

202517

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE;40MG

Approval Date

2014-01-08

Regulatory Status

Discontinued

2014
08 Jan
Discontinued Application: 202517

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;80MG

Approval Date

2014-01-08

202517 / 3

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

202517

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;80MG

Approval Date

2014-01-08

Regulatory Status

Discontinued

2014
08 Jan
Discontinued Application: 202517

Drug Name

TELMISARTAN AND AMLODIPINE

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;80MG

Approval Date

2014-01-08

202517 / 4

Active Ingredient

AMLODIPINE BESYLATE; TELMISARTAN

Application Number

202517

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;80MG

Approval Date

2014-01-08

Regulatory Status

Discontinued

2014
25 Feb
Discontinued Application: 201192

Drug Name

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;40MG

Approval Date

2014-02-25

201192 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; TELMISARTAN

Application Number

201192

Product Number

1

Dosage Form

-

Strength

12.5MG;40MG

Approval Date

2014-02-25

Regulatory Status

Discontinued

2014
25 Feb
Discontinued Application: 201192

Drug Name

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;80MG

Approval Date

2014-02-25

201192 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; TELMISARTAN

Application Number

201192

Product Number

2

Dosage Form

-

Strength

12.5MG;80MG

Approval Date

2014-02-25

Regulatory Status

Discontinued

2014
25 Feb
Discontinued Application: 201192

Drug Name

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;80MG

Approval Date

2014-02-25

201192 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; TELMISARTAN

Application Number

201192

Product Number

3

Dosage Form

-

Strength

25MG;80MG

Approval Date

2014-02-25

Regulatory Status

Discontinued

2009
27 Mar
Discontinued Application: 79153

Drug Name

TOPIRAMATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-03-27

79153 / 1

Active Ingredient

TOPIRAMATE

Application Number

79153

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2009-03-27

Regulatory Status

Discontinued

2009
27 Mar
Discontinued Application: 79153

Drug Name

TOPIRAMATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2009-03-27

79153 / 2

Active Ingredient

TOPIRAMATE

Application Number

79153

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2009-03-27

Regulatory Status

Discontinued

2009
27 Mar
Discontinued Application: 79153

Drug Name

TOPIRAMATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2009-03-27

79153 / 3

Active Ingredient

TOPIRAMATE

Application Number

79153

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2009-03-27

Regulatory Status

Discontinued

2009
27 Mar
Discontinued Application: 79153

Drug Name

TOPIRAMATE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-03-27

79153 / 4

Active Ingredient

TOPIRAMATE

Application Number

79153

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2009-03-27

Regulatory Status

Discontinued

2015
05 Jan
Discontinued Application: 202728

Drug Name

VALSARTAN

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2015-01-05

202728 / 1

Active Ingredient

VALSARTAN

Application Number

202728

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2015-01-05

Regulatory Status

Discontinued

2015
05 Jan
Discontinued Application: 202728

Drug Name

VALSARTAN

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2015-01-05

202728 / 2

Active Ingredient

VALSARTAN

Application Number

202728

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2015-01-05

Regulatory Status

Discontinued

2015
05 Jan
Discontinued Application: 202728

Drug Name

VALSARTAN

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2015-01-05

202728 / 3

Active Ingredient

VALSARTAN

Application Number

202728

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2015-01-05

Regulatory Status

Discontinued

2015
05 Jan
Discontinued Application: 202728

Drug Name

VALSARTAN

Product Number

4

Dosage Form

-

Strength

320MG

Approval Date

2015-01-05

202728 / 4

Active Ingredient

VALSARTAN

Application Number

202728

Product Number

4

Dosage Form

-

Strength

320MG

Approval Date

2015-01-05

Regulatory Status

Discontinued

2011
01 Jun
Discontinued Application: 90899

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2011-06-01

90899 / 1

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

90899

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2011-06-01

Regulatory Status

Discontinued

2011
01 Jun
Discontinued Application: 90899

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2011-06-01

90899 / 2

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

90899

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2011-06-01

Regulatory Status

Discontinued

2011
01 Jun
Discontinued Application: 90899

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2011-06-01

90899 / 3

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

90899

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2011-06-01

Regulatory Status

Discontinued

2025
28 Jan
Discontinued Application: 218180

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2025-01-28

218180 / 1

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

218180

Product Number

1

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2025-01-28

Regulatory Status

Discontinued

2025
28 Jan
Discontinued Application: 218180

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2025-01-28

218180 / 2

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

218180

Product Number

2

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2025-01-28

Regulatory Status

Discontinued

2025
28 Jan
Discontinued Application: 218180

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2025-01-28

218180 / 3

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

218180

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2025-01-28

Regulatory Status

Discontinued

2025
28 Jan
Discontinued Application: 218180

Drug Name

VENLAFAXINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 225MG BASE

Approval Date

2025-01-28

218180 / 4

Active Ingredient

VENLAFAXINE HYDROCHLORIDE

Application Number

218180

Product Number

4

Dosage Form

-

Strength

EQ 225MG BASE

Approval Date

2025-01-28

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    23 View
  • EDQM CEP
    12 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    1 View
  • FDA Approved Drugs Database
    326 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
148 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAZOLAMIDE

Application Number

213706

Product Number

1

Active Ingredient

ACETAZOLAMIDE

Dosage Form

-

Strength

125MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit